STAT+: Pfizer inks deal with UNICEF to supply Covid pill to poor countries, but advocates say it isn’t enough

“It’s better than nothing, but it’s worryingly small numbers and hardly calls for a salutary reaction toward Pfizer,” said Peter Maybarduk of Public Citizen.

As part of an effort to widen access to its Covid-19 pill, Pfizer has reached a deal with UNICEF to supply up to 4 million treatment courses to 95 low- and middle-income countries representing 53% of the global population. But consumer advocates have quickly argued the move falls short.

The agreement follows a deal the company reached last November with the Medicines Patent Pool, a public health organization backed by the United Nations, to supply its Paxlovid pill to the same 95 countries. The arrangement calls for the MPP to sub-license production rights to generic companies to then manufacture and distribute their own versions at lower prices than the Pfizer pill.

Continue to STAT+ to read the full story…